Publication: Effect of locoregional treatments in hepatocellular carcinoma: What are the pathologic/radiologic Milan Criteria?
dc.contributor.author | Aksoy, Fuat | |
dc.contributor.author | Dündar, Halit Ziya | |
dc.contributor.author | Çelik, Fatih | |
dc.contributor.author | Öngen, Gökhan | |
dc.contributor.author | Nas, Ömer Fatih | |
dc.contributor.author | Sağlam, Kutay | |
dc.contributor.author | Gürlüler, Ercüment | |
dc.contributor.author | Kıyıcı, Murat | |
dc.contributor.author | Kaya, Ekrem | |
dc.contributor.buuauthor | AKSOY, FUAT | |
dc.contributor.buuauthor | DÜNDAR, HALİT ZİYA | |
dc.contributor.buuauthor | ÇELİK, FATİH | |
dc.contributor.buuauthor | ÖNGEN, GÖKHAN | |
dc.contributor.buuauthor | NAS, ÖMER FATİH | |
dc.contributor.buuauthor | SAĞLAM, KUTAY | |
dc.contributor.buuauthor | GÜRLÜLER, ERCÜMENT | |
dc.contributor.buuauthor | KIYICI, MURAT | |
dc.contributor.buuauthor | KAYA, EKREM | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Organ Nakli Merkezi. | |
dc.contributor.orcid | 0000-0001-5808-9384 | |
dc.contributor.orcid | 0000-0003-2728-9521 | |
dc.contributor.researcherid | HII-8895-2022 | |
dc.contributor.researcherid | X-7425-2018 | |
dc.contributor.researcherid | EWI-3634-2022 | |
dc.contributor.researcherid | JYY-5340-2024 | |
dc.contributor.researcherid | FQR-8472-2022 | |
dc.contributor.researcherid | JJS-3965-2023 | |
dc.contributor.researcherid | JSD-3843-2023 | |
dc.contributor.researcherid | FHW-0015-2022 | |
dc.contributor.researcherid | JSF-3184-2023 | |
dc.date.accessioned | 2024-10-07T12:50:26Z | |
dc.date.available | 2024-10-07T12:50:26Z | |
dc.date.issued | 2023-10-01 | |
dc.description.abstract | Objectives: Milan criteria is the most commonly used criteria for patients with hepatocellular carcinoma awaiting liver transplant. The effects of locoregional therapy on downstaging or bridging before liver transplant on survival remain controversial. Considering that the tumor size may change with locoregional therapy and formalin fixation after explantation, we aimed to evaluate the effects of locoregional therapy on radiological and pathological Milan criteria and survival.Materials and Methods: Demographic data, etiology, preoperative alpha-fetoprotein value, Child-Pugh and Model for End-Stage Liver Disease-Na scores, status of being inside or outside of radiological Milan criteria, status of being inside or outside of Milan criteria in explant (pathological Milan criteria), and the locoregional therapy types and combinations were evaluated for their effects on inclusion in Milan criteria and survival.Results: During the study period, 396 patients underwent liver transplant at our center, with 97 because of cirrhosis and hepatocellular carcinoma. When we viewed patients according to preoperative radiologic evaluations, 67.9% were within Milan criteria and 32.1% were outside. When we viewed according to explant (pathological) evaluations, 80.7% of patients were within Milan criteria. Among 97 patients, 71 (73.2%) had locoregional therapy (22 [30.9%] for downstaging, 49 [69.0%] for bridging to transplant), and 12 patients (12.3%) were within Milan criteria on explant examination while outside of Milan criteria before LT. One-year, 3-year, and 5-year survival rates were 80.7%, 76.1%, and 71.6%, respectively. Conclusions: As a result of radiological evaluations, in patients who were outside of Milan criteria and underwent locoregional therapy, explant pathology within Milan criteria had a positive effect on survival; however, after locoregional therapy, there was no significant effect on survival in patients who were still outside of Milan criteria. | |
dc.identifier.doi | 10.6002/ect.2023.0221 | |
dc.identifier.endpage | 825 | |
dc.identifier.issn | 1304-0855 | |
dc.identifier.issue | 10 | |
dc.identifier.startpage | 820 | |
dc.identifier.uri | https://doi.org/10.6002/ect.2023.0221 | |
dc.identifier.uri | https://www.ectrx.org/detail/archive/2023/21/10/0/820/0 | |
dc.identifier.uri | https://hdl.handle.net/11452/45997 | |
dc.identifier.volume | 21 | |
dc.identifier.wos | 001101358600005 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Başkent Üniversitesi | |
dc.relation.journal | Experimental and Clinical Transplantation | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Liver-transplantation | |
dc.subject | Radiofrequency ablation | |
dc.subject | Candidates | |
dc.subject | Survival | |
dc.subject | Fixation | |
dc.subject | Cancer | |
dc.subject | Bridge | |
dc.subject | Risk | |
dc.subject | Bridge to transplant | |
dc.subject | Downstaging | |
dc.subject | Locoregional therapy | |
dc.subject | Transplantation | |
dc.title | Effect of locoregional treatments in hepatocellular carcinoma: What are the pathologic/radiologic Milan Criteria? | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 9188647a-59b3-41bd-be73-594de198226a | |
relation.isAuthorOfPublication | 389d770a-876f-404b-b17b-395dbdd9fd62 | |
relation.isAuthorOfPublication | 627ffe27-e48c-49fa-9181-b12323b59501 | |
relation.isAuthorOfPublication | edae7686-a2e3-4d00-8b8b-76c9ab110f2d | |
relation.isAuthorOfPublication | 2aa7fdf5-f110-441f-b7ea-0d829a69f47b | |
relation.isAuthorOfPublication | 546a5dc5-7d80-44a9-a0b5-9a3846caa5b7 | |
relation.isAuthorOfPublication | fe543665-a7d3-48b1-951c-f7529a954e8c | |
relation.isAuthorOfPublication | b364b52b-c416-4987-b080-93f6f81ecb3e | |
relation.isAuthorOfPublication | d9a7ba60-69d8-45ca-af06-be3461e5ab36 | |
relation.isAuthorOfPublication.latestForDiscovery | 9188647a-59b3-41bd-be73-594de198226a |